Ikoma Technologies Q1 Results: Net loss narrows 45% YoY to ₹5.82 lakh

1 min read     Updated on 15 Aug 2026, 01:08 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Ikoma Technologies reported a standalone net loss of ₹5.82 lakh for Q1FY27, down significantly from ₹105.14 lakh in Q1FY26. Total income from operations was ₹112.18 lakh, lower than the ₹254.87 lakh recorded in the prior year period. The board approved the results on August 14, 2026.

powered bylight_fuzz_icon
48325084

*this image is generated using AI for illustrative purposes only.

Ikoma Technologies reported a narrowed net loss for the first quarter of fiscal year 2027, with standalone results showing improved profitability metrics compared to the previous year. The company, formerly known as Vuenow Infratech Limited, posted a net loss of ₹5.82 lakh for the quarter ended June 30, 2026, a significant reduction from the ₹105.14 lakh loss recorded in the same period of FY26.

Total income from operations for Q1FY27 was ₹112.18 lakh, compared to ₹254.87 lakh in Q1FY26. The sequential performance also showed improvement, as the net loss contracted from ₹96.29 lakh in the immediately preceding quarter (Q4FY26) to ₹5.82 lakh in the current period.

Financial Highlights

The unaudited standalone financial results, approved by the Board of Directors on August 14, 2026, reflect the following key metrics:

Metric: Q1FY27 Q4FY26 Q1FY26
Total Income from Operations: ₹112.18 lakh ₹274.51 lakh ₹254.87 lakh
Net Profit / (Loss) Before Tax: (₹5.82 lakh) (₹96.29 lakh) (₹105.14 lakh)
Net Profit / (Loss) After Tax: (₹5.82 lakh) (₹96.19 lakh) (₹105.14 lakh)
Total Comprehensive Income: (₹5.82 lakh) (₹96.19 lakh) (₹105.14 lakh)

The company’s equity share capital remained unchanged at ₹5,839.16 lakh. Earnings per share (basic and diluted) were reported at nil for the quarter.

What the Numbers Show

A notable divergence exists between revenue trends and profitability improvements. While total income from operations declined sequentially from ₹274.51 lakh in Q4FY26 to ₹112.18 lakh in Q1FY27, the net loss contracted sharply by over 94% during the same period (from ₹96.29 lakh to ₹5.82 lakh). This suggests that cost structures or operational expenses may have been adjusted more aggressively than top-line revenue generation in the current quarter.

The financial results were published in accordance with Regulation 30 and Regulation 47 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The newspaper advertisement containing the statement of standalone unaudited financial results was published on August 15, 2026, in Active Times (English) and Mumbai Lakshadeep (Marathi).

Rahul Anandrao Bhargav, Managing Director of Ikoma Technologies, signed off on the disclosure.

Historical Stock Returns for Ikoma Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+0.24%+3.30%+1.72%+228.58%-8.88%+3,230.88%

What specific cost-cutting measures or operational adjustments enabled Ikoma Technologies to contract its net loss by over 94% despite a significant decline in operating income?

How does the company plan to reverse the sequential revenue drop from ₹274.51 lakh in Q4FY26 to ₹112.18 lakh in Q1FY27 in upcoming quarters?

Will Ikoma Technologies aim for net profitability in Q2FY27 given the sharp improvement in loss metrics, and what are the key drivers for this potential turnaround?

Ikoma Technologies postpones Q1FY26 results meeting to Aug 14

0 min read     Updated on 13 Aug 2026, 07:20 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Ikoma Technologies Limited postponed its Q1FY26 results meeting from August 13 to August 14, 2026, due to a medical emergency involving the MD. The trading window for insiders remains closed until 48 hours post-result declaration.

powered bylight_fuzz_icon
48174649

*this image is generated using AI for illustrative purposes only.

Ikoma Technologies Limited has postponed its board of directors meeting, originally scheduled for Thursday, August 13, 2026, to Friday, August 14, 2026. The company cited a medical emergency involving its Managing Director as the reason for the delay.

The rescheduled meeting will be held via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The primary agenda includes considering and approving the unaudited standalone financial results for the quarter ended June 30, 2026, along with the limited review report.

Trading Window Status

The trading window for directors, promoters, designated employees, and connected persons remains closed. This closure began on July 1, 2026, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will reopen 48 hours after the declaration of the unaudited financial results.

This announcement follows a previous intimation dated August 7, 2026, regarding the initial schedule. The company notified the BSE Limited pursuant to Regulation 29 of the SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015.

Historical Stock Returns for Ikoma Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+0.24%+3.30%+1.72%+228.58%-8.88%+3,230.88%

How might the Managing Director's medical emergency impact the company's strategic decision-making and operational continuity in the near term?

Will the one-day delay in approving Q2 financial results affect investor sentiment or trigger short-term volatility in Ikoma Technologies' stock price?

Are there any indications that the financial results for the quarter ended June 30, 2026, will deviate significantly from market expectations given the scheduling disruption?

More News on Ikoma Technologies

1 Year Returns:-8.88%